2023 MIT Startup Showcase in Seoul presents an opportunity to learn about various MIT-connected startups across a diverse set of industries, including Artificial Intelligence, Energy, Life Sciences, Robotics, Sustainability, and Proptech.
The MIT Startup Exchange Lightning Talks listed below are part of the full agenda for the 2023 MIT Startup Showcase (Seoul).
The agenda for the day includes a series of insightful lightning talks, exhibitions showcasing the work of innovative startups, and networking sessions with professionals from MIT-connected startups, as well as the larger industry.
The event is a collaborative effort between the MIT Industrial Liaison Program and MIT Startup Exchange; both committed to fostering collaboration and partnerships between MIT-connected startups and industry. The participating startups are part of MIT Startup Exchange, having either been built on licensed MIT technology (co) founded by MIT faculty, staff, or alumni or vetted and supported by MIT Startup Exchange peers. Currently, MIT Startup Exchange's network includes over 1,000 startups.
Co-Founder & CEO, 3D Architect
Kai Narita is an innovator and engineer leading the 3D printing technology development. He has a Ph.D. in Materials Science from the California Institute of Technology (Caltech) and received his master’s in Engineering and bachelor’s degree from the Tokyo Institute of Technology.
Co-Founder & CTO, Capra Bioscience
Andrew Magyar is the Co-Founder and CTO of Capra Biosciences. Dr. Magyar is a co-inventor of the Capra Biosciences biofilm reactor technology and has more than 20 years of R&D experience in Biotechnology and Advanced Materials. Dr. Magyar has a Ph.D. in Materials Science from MIT, where he worked with Prof. Angela Belcher developing new biobased materials for sustainable energy applications. As a post-doctoral fellow at Harvard University, Dr. Magyar worked on developing new materials and devices for quantum information technology and studied how cuttlefish change colors. In his previous role at Draper, an R&D non-profit, Magyar led multidisciplinary teams of more than 30 researchers to develop complex new hardware technologies for synthetic biology.
Chief of Staff, Cellino
Willie T. Reaves Jr. is the Chief of Staff at Cellino, which is building a technology platform to make personalized human cells available for all patients. He leads the company’s government affairs & policy activities, and public engagement. Prior to joining Cellino, Willie was the Chief Business Strategy Innovation Officer at the Biotechnology Innovation Organization (BIO), where he oversaw product development and global B2B partnership operations for the signature BIO One-on-One Partnering platform and spearheaded BIO Business Solutions, the life science industry's largest cost savings program. Before joining BIO, Willie was a project manager and teacher in South Korea, and he worked in the Patent Group at the Emory University Office of Technology Transfer. Outside of work, Willie serves on the National Leadership Council of the Society for Science, a nonprofit organization dedicated to expanding scientific literacy and access to STEM education & scientific research.
Chief Scientist, Cleanlab
Jonas Mueller is Chief Scientist at Cleanlab, a company that's invented Data-Centric AI software to automatically find and fix issues in raw datasets. Previously, Mueller was a senior scientist at Amazon Web Services, developing AutoML and Deep Learning algorithms which now power ML applications at hundreds of the world's largest companies. In 2018, he completed his Ph.D. in Machine Learning at MIT, also doing research in NLP, Statistics, and Computational Biology. Jonas has published over 30 papers in top ML and Data Science venues (NeurIPS, ICML, ICLR, AAAI, JASA, Annals of Statistics, etc.). This research has been featured in Wired, VentureBeat, Technology Review, World Economic Forum, and other media. He also helped create the fastest-growing open-source software for AutoML and Data-Centric AI, and at MIT, he taught the first-ever course on Data-Centric AI.
Co-Founder & CEO, Common Sense Machines
Tejas Kulkarni is the Co-founder and CEO of Common Sense Machines (CSM). In 2016, Tejas obtained his Ph.D. from MIT's Brain and Cognitive Science Department under the supervision of Professor Josh Tenenbaum. He then served as a senior research scientist at DeepMind until 2019. His research has driven breakthroughs in three key areas: vision as inverse graphics, deep generative models for multi-modal inputs, and data-efficient deep reinforcement learning. This high-impact work has been recognized with best paper awards at prestigious conferences such as CVPR and EMNLP.
Co-Founder & CEO, iSee
Yibiao Zhao, ISEE CEO and Co-founder has a Ph.D. in Computer Vision, AI, Robotics, and Machine Learning. His transformational work at UCLA and MIT defined how human reasoning can be applied to AI and robotics. This led him to found ISEE in 2017 and apply his work in AI to create autonomous vehicles. He focuses on automating the supply chain and logistics space through autonomous yard trucks in warehouses, ports, and depots. Led by Yibiao, ISEE is now growing its fleet and deploying autonomous technology in yards throughout the U.S. With ISEE solutions at the logistics hubs; yard operators can automate the manual, repetitive tasks that have historically slowed them down. As evidence of ISEE’s breakthrough solution, SupplyTech Breakthrough awarded ISEE Autonomous Truck of the Year 2023.
Lead - Strategy & Business Development, Lamarr.AI
Benjamin Rocci heads the business development for Lamarr.ai. He is an MBA graduate from the MIT Sloan School of Management, where, as a student, he helped found a manufacturing tech startup, which he now advises. Prior to his time at MIT, Ben spent over six years with Ford Motor Company in roles spanning across connected vehicle engineering and technology strategy. He holds a B.S. in Electrical Engineering from Villanova University.
Co-Founder & CTO, Manus Robotics
Dr. Faye Wu (S.B. '09, S.M. '12, Ph.D. '17) is the CTO and a co-founder of Manus Robotics, a wearable technology startup dedicated to improving human capabilities. While at MIT, Faye researched medical device design, instrumentation, robotics control, and machine learning. The team she led, developing a device to help those with macular degeneration, was selected as a winner of the IDEAS Global Challenge and a finalist of the World Technology Awards. She also invented the Supernumerary Robotic Fingers, a wrist-mounted robot that assists hemiplegic patients with activities of daily living, which prompted the founding of Manus Robotics. Besides overseeing the R&D efforts at Manus, Faye has led the team to win various awards and recognitions, including receiving multiple NSF Small Business Innovation Research grants and being selected as a finalist of the 2021 MassChallenge Houston cohort.
Co-Founder & CTO, Metanovas Biotech
Dr. Lun Yu is the Co-Founder and CTO at Metanovas Biotech. He oversees AI research, peptide pipeline development, engineering infrastructure, and software development. Before Metanovas, Dr. Yu led the Personalization Team at Optum Digital (United Health Group), managing flagship digital health products with over $180 million annual values. Dr. Yu holds a Ph.D. in Nuclear Science and Engineering from MIT and was awarded as Top 30 Under 30 by All-American Chinese Youth Federation.
Co-Founder & CEO, Numb Corp.
Andrew Radin is CEO & Co-Founder of Numb Corp. Previously, he co-founded Aria Pharmaceuticals (f.k.a. twoXAR), where he led activities in fundraising, communications, business development, and recruiting, yielding two rounds of funding and Aria’s first six partnerships. Andrew has coached and advised dozens of entrepreneurs independently and through MIT, Stanford, UC San Diego, and the University of Hawaii innovation and entrepreneurship programs. He previously co-founded Thyme Labs and was a part of Macquarie Bank’s Private Markets team. Andrew earned an MBA from MIT Sloan and bachelor's degrees in biochemistry and economics from the University of California San Diego.
Founder & CEO, Stitch3D
Clark Yuan is a former US Army Intelligence Officer and is a current Army innovation officer. He founded Stitch3D to help defense and government clients more easily manage, analyze, and collaborate with 3D data on the cloud. The company received R&D funding from the US Air Force to develop a platform that can assist with rapid 3D damage assessment occurring from natural disasters or battlefield conditions. Stitch3D is now looking to commercialize its secure 3D data platform to help the industry with large-point cloud data management and analytical needs. Clark is a West Point graduate who earned MPA/MBA degrees from the Harvard Kennedy School and MIT Sloan.
Co-Founder & CEO, Themis AI
Elaheh Ahmadi is the CEO and co-founder of Themis AI, an MIT spinout with the mission to empower the world to create, advance, and deploy trustworthy AI. At Themis, we bring an end-to-end Risk Aware AI Workflow to the industry. We are solving the challenges in AI that even the most high-tech companies haven’t been able to solve. Our technology identifies and mitigates risks within AI models end-to-end throughout the AI lifecycle. We enable trust, robustness, and fairness in AI from data curation to model deployment.
Co-Founder & CTO, Tulip Interfaces
Bio coming soon.
Co-Founder & CEO, Ubicept
Sebastian Bauer is the co-founder and CEO of Ubicept, which provides new imaging solutions that can see in challenging environments such as very low light and very bright light, and even around corners. He has spent his career exploring new kinds of imaging with a focus on signal processing and information extraction. He holds BS/MS/Ph.D. degrees in Electrical Engineering from the Karlsruhe Institute of Technology (KIT), Germany.
Co-Chief Technology Officer & Vice President, Engineering, Venti Technologies
Dr. James Fu is co-Chief Technology Officer and Vice President, Engineering of Venti Technologies. He is also a co-founder of Venti Singapore. A world expert in automation and engineering, Dr. Fu manages the development of Venti’s complete autonomy systems for fully driverless systems. Dr. Fu’s distinguished career in autonomous vehicles began at the Singapore-MIT Alliance for Research and Technology (SMART) – MIT’s first research center outside of Cambridge, MA, and its largest international research endeavor – where he led notable research advancements in autonomous transportation. It was at SMART where, in 2014, Dr. Fu launched the world’s first public trial of self-driving golf carts—500 public rides—at Singapore’s Chinese Gardens. Dr. Fu built and led the founding technical team (from 10 to 200 people during his tenure) at nuTonomy – an MIT spin-off that developed software for self-driving cars – and oversaw nuTonomy’s technology development to become a top global robotaxi company resulting in a $450m acquisition by Delphi/Aptiv. Dr. Fu continues to work with Singapore’s Land Transport Authority to develop national standards; design and implement public education programs; and define core behaviors, operating principles, and regulation for self-driving vehicles. Dr. Fu earned his B.Eng. (2005) and Ph.D. (2012) in Mechanical Engineering from the National University of Singapore. He holds 10 core autonomy patents under his name.
Disclaimer: MIT Startup Exchange can make introductions that ideally provide open ended discussions in order to share mutual interests and potentially create common ground that incite the parties to collaborate. MIT Startup Exchange introductions may eventually lead to mutual partnerships, but that is not in any way guaranteed by MIT, MIT Corporate Relations, MIT Industrial Liaison Program (ILP) or MIT Startup Exchange, which takes no responsibility for these outcomes and no formal part in such discussions following our introduction. MIT Startup Exchange and its activities and events are not for purposes of soliciting investment or offering securities.